Anticholinergic treatment of Parkinson's disease
Ascher, P.W.
Wiener Klinische Wochenschrift 88(19): 641-646
1976
ISSN/ISBN: 0043-5325 PMID: 790774 Document Number: 101663
Anticholinergic drugs retain their place even today in the treatment of Parkinson's disease in spite of the considerable success achieved by means of stereotactic surgery and substitution therapy with dopa or dopa derivatives. An investigation was made on 44 patients suffering from Parkinson's disease treated with the new anticholinergic drug, Sormodren (Knoll). Sormodren showed a selective action on the hyperkinetic and autonomic symptoms of this disease of the extrapyramidal system. Tolerance was good, no serious side effects being observed.